Cytek Biosciences
CTKB
CTKB
84 hedge funds and large institutions have $568M invested in Cytek Biosciences in 2022 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
10% more capital invested
Capital invested by funds: $515M → $568M (+$53.3M)
3.78% more ownership
Funds ownership: 35.59% → 39.37% (+3.8%)
Holders
84
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$22.5M | |
| 2 | +$11.2M | |
| 3 | +$9.84M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.71M |
| 5 |
Millennium Management
New York
|
+$8.42M |
Top Sellers
| 1 | -$6.5M | |
| 2 | -$6.16M | |
| 3 | -$5.65M | |
| 4 |
D.E. Shaw & Co
New York
|
-$5.61M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.34M |